Burning Rock Biotech Q4 EPS $(0.22) Up From $(0.31) YoY, Sales $17.10M Down From $20.62M YoY
Burning Rock Biotech Q4 EPS $(0.22) Up From $(0.31) YoY, Sales $17.10M Down From $20.62M YoY
Burning Rock Biotech第四季度每股收益为0.22美元，高于同比0.31美元，销售额为1710万美元，低于同比2,062万美元
Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.22) per share. This is a 29.03 percent increase over losses of $(0.31) per share from the same period last year. The company reported $17.10 million in sales this quarter. This is a 17.08 percent decrease over sales of $20.62 million the same period last year.
Burning Rock Biotech（纳斯达克股票代码：BNR）公布的季度亏损为每股0.22美元。与去年同期每股亏损0.31美元（0.31）相比，增长了29.03％。该公司报告本季度销售额为1710万美元。这比去年同期的2,062万美元的销售额下降了17.08％。